市场调查报告书
商品编码
1464944
CBD 成分市场:按来源、类型和应用分类 - 2024-2030 年全球预测CBD Ingredients Market by Source (Hemp-Derived CBD, Marijuana-Derived CBD), Type (Broad Spectrums, Full Spectrums, Isolate Spectrums), Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
CBD原料市场规模预计2023年为65.2亿美元,2024年达到73.8亿美元,预计2030年将达到163.8亿美元,复合年增长率为14.05%。
大麻二酚 (CBD) 成分市场包括植物来源的所有产品和成分,特别关注 CBD,这是一种以其潜在健康益处而闻名的非精神活性化合物。由于其应用范围广泛,该市场延伸至药品、化妆品、食品和饮料、宠物护理等各个领域。这涉及从种植和提取到将 CBD 注入的产品分销给最终消费者,凸显了复杂的价值链。 CBD成分应用于药品、营养补充、化妆品、食品食品和饮料等各领域。在药物领域,CBD 用于治疗焦虑、癫痫和慢性疼痛等疾病。在营养补充领域,将其纳入促进健康的补充品中。含有 CBD 的化妆品以其发炎和抗氧化特性而闻名,食品和饮料行业正在使用 CBD 来创造以健康为导向的食用产品。有几个因素正在推动 CBD 成分市场的成长,包括全球慢性病的流行、CBD 成分研发投资的增加以及消费者对健康和自然疗法的兴趣日益浓厚。然而,大麻二酚市场面临着一定的挑战,包括 CBD 产品严格的品质和安全标准、消费者的误解以及围绕大麻产品的耻辱。同时,新的 CBD 配方和输送方法的持续开发,以及与食品、食品和饮料、化妆品和製药公司的策略合作伙伴关係,为 CBD 成分市场提供了潜在的成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 65.2亿美元 |
预测年份 [2024] | 73.8亿美元 |
预测年份 [2030] | 163.8亿美元 |
复合年增长率(%) | 14.05% |
类型治疗效果增加了对全光谱CBD 的偏好
频谱CBD 具有天然大麻素的综合特征,不包括 THC(四氢大麻酚)。由于大麻素和萜烯的综合作用,这种类型的 CBD 提供了一种娱乐效果,被认为可以增加产品的整体效力,而不会产生与 THC 相关的精神作用。全光谱CBD 含有大麻植物中发现的所有大麻素,包括 THC。这种成分保持了植物化学成分的完整性,并提供了 CBD 消费的整体方法。 THC 的存在,即使是微量,与其他大麻素和萜烯一起,也可以有助于娱乐效果并增强产品的治疗效果。 隔离群 频谱 CBD,通常称为 CBD隔离群,几乎是 100% 纯 CBD。在萃取过程中,所有其他大麻素、萜烯和类黄酮都被移除,产生仅含有大麻二酚的产品。这种类型的 CBD 成分不含 THC 或大麻植物中发现的其他化合物,使其成为寻求 CBD 纯粹功效而不受其他大麻素或萜烯影响的消费者的好选择。它常见于依赖 CBD 纯度和浓度的製药应用、某些营养补充食品针对特定健康目标的产品。
将 CBD 成分的应用扩展到支持整体健康的营养补充
在食品和饮料领域,CBD 主要用于其潜在的健康益处,而不具有与 THC 相关的精神作用。含有 CBD 的饮料、巧克力和烘焙点心等产品迎合了寻求放鬆、减少焦虑和改善睡眠品质的消费者。该行业受益于天然和健康产品的持续趋势。 CBD 因其发炎、镇痛和神经保护特性而受到食品营养补充的欢迎。该细分市场的消费者专注于健康和保健,并利用 CBD 的潜力来提振情绪、帮助运动后恢復和支持整体健康。在个人护理和化妆品行业,CBD 的发炎和抗氧化特性被用于护肤产品,如乳霜、精华液和香膏。这些产品的目标使用者是寻找促进皮肤健康、缓解痤疮等状况并提供抗老化功效的天然成分的使用者。在製药领域,CBD 的用途多种多样,主要集中在其治疗特定医疗状况的潜力。目前正在研究 CBD 对癫痫、焦虑症、多发性硬化症和癌症等慢性疾病症状管理的有效性。总之,市场区隔是多种多样的,每个应用领域都针对特定的消费者需求和偏好。食品和饮料、食品营养补充于一般健康促进和健康优化,而个人护理、化妆品和药品则着重于解决特定健康状况或促进皮肤健康的产品。
区域洞察
由于合法化、社会接受度的提高以及 CBD 产品的扩张,以美国和加拿大为中心的北美地区仍然是 CBD 成分的主要市场。特别是在美国,2018 年农业法案后的监管发展正在支持 CBD 在消费和製药领域的扩张。南美洲注意到人们对 CBD 成分的兴趣激增,特别是乌拉圭和哥伦比亚正在采取积极措施实现大麻合法化。该地区在农业能力和监管转变的支持下显示出成长潜力。欧洲 CBD 市场呈现出监管多样性,在有利的法规环境和高消费者兴趣的推动下,德国、英国和瑞士等国家处于领先地位。然而,欧盟的新型食品法规标誌着一个重要的监管里程碑,为 CBD食品和补充品铺平了道路。中东对于 CBD 产品来说是一个充满挑战的市场,许多国家都有严格的大麻管制法。然而,人们对 CBD 的药用兴趣不大,但日益增长。非洲 CBD 市场正处于早期开拓阶段,其中南非是最引人注目的市场。由于人们对 CBD 的健康和保健益处的认识不断增强,非洲大陆在种植大麻和开拓CBD 市场方面都表现出了希望。亚太地区对 CBD 的兴趣正在缓慢但稳定地增长,这主要是由澳大利亚和泰国等国家推动的。儘管对 CBD 消费有严格的监管,但中国已成为 CBD 大麻种植和出口市场的重要参与者。中国最近的专利集中在大麻遗传学和 CBD 萃取技术上。日本对THC保持严格的零容忍政策,并强调CBD的纯度。最近的放鬆管制导致注入 CBD 的产品数量增加,从护肤到补充品。印度的 CBD 市场正处于起步阶段,普及还有重大的法律和文化障碍。然而,阿育吠陀中大麻的传统用途和日益增长的意识表明了未来的市场潜力。
FPNV定位矩阵
FPNV定位矩阵对于评估CBD成分市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对 CBD 成分市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.CBD原料市场的市场规模与预测是多少?
2. CBD 成分市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些?
3.CBD原料市场的技术趋势与法规结构是什么?
4.CBD原料市场主要供应商的市场占有率是多少?
5.进入CBD原料市场的合适型态和策略手段是什么?
[180 Pages Report] The CBD Ingredients Market size was estimated at USD 6.52 billion in 2023 and expected to reach USD 7.38 billion in 2024, at a CAGR 14.05% to reach USD 16.38 billion by 2030.
The cannabidiol (CBD) ingredients market includes all products and raw materials derived from the hemp plant, specifically focusing on CBD, a non-psychoactive compound known for its potential health benefits. The market spans various sectors, including pharmaceuticals, cosmetics, food and beverages, and pet care, owing to its broad application range. The scope extends from cultivation and extraction to distributing CBD-infused products to end consumers, highlighting an intricate value chain. CBD ingredients find applications across various sectors, including pharmaceuticals, nutraceuticals, cosmetics, and food and beverages. In pharmaceuticals, CBD is used for its therapeutic properties in treating conditions such as anxiety, epilepsy, and chronic pain. In the nutraceutical sector, it is incorporated into supplements for wellness benefits. Cosmetics infused with CBD are known for their anti-inflammatory and antioxidant properties, while the food and beverage industry utilizes CBD to create wellness-oriented edible products. Several factors propel the growth of the CBD ingredients market, including the growing prevalence of chronic diseases globally, increased investment in R&D of CBD ingredients, and increasing consumer focus on wellness and natural remedies. However, the cannabidiol market is facing certain challenges, such as stringent quality and safety standards required for CBD products, consumer misconceptions, and the stigma associated with cannabis products. On the other hand, the ongoing development of novel CBD formulations and delivery methods and strategic partnerships with food, beverage, cosmetics, and pharmaceutical companies present potential growth opportunities for the CBD ingredients market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 6.52 billion |
Estimated Year [2024] | USD 7.38 billion |
Forecast Year [2030] | USD 16.38 billion |
CAGR (%) | 14.05% |
Type: Increasing preference for full spectrum CBD due to its therapeutic benefits
Broad Spectrum CBD is characterized by its comprehensive profile of naturally occurring cannabinoids, excluding THC (tetrahydrocannabinol). This type of CBD offers the entourage effect, whereby the combined effect of cannabinoids and terpenes is believed to enhance the product's overall efficacy without the psychoactive effects associated with THC. Full Spectrum CBD includes all cannabinoids found in the cannabis plant, including THC. This composition maintains the integrity of the plant's chemical profile, offering a holistic approach to CBD consumption. The presence of THC, even in minimal amounts, along with additional cannabinoids and terpenes, contributes to the entourage effect, potentially increasing the therapeutic benefits of the product. Isolate Spectrum CBD, often referred to as CBD Isolate, is nearly 100% pure CBD. During the extraction process, all other cannabinoids, terpenes, and flavonoids are removed, resulting in a product that contains solely cannabidiol. This type of CBD ingredient is free from THC and any other compounds found in the cannabis plant, making it a suitable option for consumers looking for the pure effects of CBD without the influence of other cannabinoids or the terpene profile. It's commonly found in pharmaceutical applications, certain dietary supplements, and products targeting specific wellness goals that rely on the purity and concentration of CBD.
Application: Expanding application of CBD ingredients in nutraceuticals & dietary supplements to support overall health
In the food & beverage sector, CBD is predominantly utilized for its potential health benefits without the psychoactive effects associated with THC. Products such as CBD-infused beverages, chocolates, and baked goods cater to consumers seeking relaxation, reduced anxiety, and improved sleep quality. This sector benefits from the ongoing trend towards natural and wellness-focused products. The nutraceuticals & dietary supplements segment embraces CBD for its anti-inflammatory, analgesic, and neuroprotective properties. Consumers in this segment focus on health and wellness, leveraging CBD's potential to enhance mood, aid in recovery post-exercise, and support overall health. In the personal care & cosmetics industry, CBD's anti-inflammatory and antioxidant properties are harnessed in products aimed at skin care, such as creams, serums, and balms. These items target users looking for natural ingredients to enhance skin health, alleviate conditions including acne, and provide anti-aging benefits. The pharmaceutical sector presents a significantly different application for CBD, focusing on its therapeutic potential for treating specific medical conditions. There is ongoing research into CBD's effectiveness for epilepsy, anxiety disorders, and symptom management for chronic diseases such as multiple sclerosis and cancer. In conclusion, the CBD ingredients market is diverse, with each application segment catering to specific consumer needs and preferences. While food & beverage and nutraceuticals & dietary supplements focus on general wellness and health optimization, personal care & cosmetics and Pharmaceutical segments leverage CBD's therapeutic potential to address specific health conditions and enhance skin health.
Regional Insights
The North American region, notably the United States and Canada, continues to be a major market for CBD ingredients due to increasing legalization, societal acceptance, and an expanding array of CBD-infused products. Regulatory advancements, especially in the U.S. following the 2018 Farm Bill, have supported the expansion of CBD in both consumer and pharmaceutical domains. In South America, the burgeoning interest in CBD ingredients is noteworthy, particularly in Uruguay and Colombia, which have taken progressive steps toward cannabis legalization. This region shows growth potential bolstered by agricultural capabilities and regulatory shifts. Europe's CBD market exhibits considerable diversity in regulation and countries such as Germany, the UK, and Switzerland are at the forefront, driven by favorable regulatory atmospheres and high consumer interest. However, the EU's Novel Food Regulation has been a critical regulatory milestone, providing a pathway for CBD foods and supplements. The Middle East presents a challenging market for CBD products, with stringent anti-cannabis laws across many countries. However, there is a small but growing interest in CBD for medicinal purposes. Africa's CBD market is in early development, with South Africa being the most notable market. The continent shows potential for both the cultivation of hemp and the development of CBD markets, driven by a growing awareness of CBD's health and wellness benefits. The APAC region is witnessing a slow but steady interest in CBD, primarily led by countries such as Australia and Thailand. China is appearing as a significant player in the CBD hemp cultivation and export markets despite stringent regulations around CBD consumption. Recent patents in China focus on hemp genetics and CBD extraction technologies. Japan maintains a strict zero-tolerance policy for THC, placing an emphasis on CBD purity. Recent regulatory relaxations have led to an increase in available CBD-infused products, from skincare to supplements. India's CBD market is in its nascent stages, with significant legal and cultural barriers to widespread adoption. However, the traditional use of cannabis in Ayurvedic practices and growing awareness signal a future market potential.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the CBD Ingredients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CBD Ingredients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the CBD Ingredients Market, highlighting leading vendors and their innovative profiles. These include Aurora Cannabis Inc., Bedrocan, BIOTA Biosciences LLC, CannazALL, Cannoid LLC, Canopy Growth Corp., CBD American Shaman LLC, CV Sciences, Inc., Elixinol, Endoca BV, Folium Biosciences, Gaia Botanics, Global Cannabinoids, Green Roads Inc., Happie Hemp Pvt. Ltd., Isodiol International Inc,, Kazmira LLC, Maricann, Inc., Medical Marijuana Inc., Mile High Labs International Inc., NuLeaf Naturals, LLC, PharmaHemp d.o.o., Rhizo Sciences, Sequoya, and SPARKCBD.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the CBD Ingredients Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CBD Ingredients Market?
3. What are the technology trends and regulatory frameworks in the CBD Ingredients Market?
4. What is the market share of the leading vendors in the CBD Ingredients Market?
5. Which modes and strategic moves are suitable for entering the CBD Ingredients Market?